PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.06 - 0.06
0.06 - 0.24
2.78M / 3.59M (Avg.)
-1.55 | -0.04
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.58%
Negative revenue growth while NHC.AX stands at 7.35%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
46.64%
Gross profit growth above 1.5x NHC.AX's 16.27%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
191.76%
Positive EBIT growth while NHC.AX is negative. John Neff might see a substantial edge in operational management.
90.24%
Operating income growth above 1.5x NHC.AX's 15.63%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
153.85%
Net income growth above 1.5x NHC.AX's 51.80%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
154.17%
EPS growth above 1.5x NHC.AX's 40.74%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
154.17%
Diluted EPS growth above 1.5x NHC.AX's 46.15%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.57%
Share reduction while NHC.AX is at 5.11%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.57%
Reduced diluted shares while NHC.AX is at 6.15%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
169.21%
Positive OCF growth while NHC.AX is negative. John Neff would see this as a clear operational advantage vs. the competitor.
133.22%
Positive FCF growth while NHC.AX is negative. John Neff would see a strong competitive edge in net cash generation.
No Data
No Data available this quarter, please select a different quarter.
-56.59%
Negative 5Y CAGR while NHC.AX stands at 53.81%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-72.78%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
117.39%
10Y OCF/share CAGR under 50% of NHC.AX's 355.06%. Michael Burry would worry about a persistent underperformance in cash creation.
144.23%
5Y OCF/share CAGR is similar to NHC.AX's 141.95%. Walter Schloss might see parallel cost profiles or expansions producing comparable cash flow.
-87.51%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
101.21%
Below 50% of NHC.AX's 1467.85%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
119.90%
Below 50% of NHC.AX's 356.47%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-94.42%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-55.05%
Negative equity/share CAGR over 10 years while NHC.AX stands at 31.33%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
62.39%
5Y equity/share CAGR above 1.5x NHC.AX's 27.32%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
525.13%
3Y equity/share CAGR above 1.5x NHC.AX's 23.72%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
2.37%
Below 50% of NHC.AX's 132.56%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
82.91%
Inventory growth well above NHC.AX's 12.27%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-5.14%
Negative asset growth while NHC.AX invests at 1.97%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-1.07%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-2.47%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
12.63%
SG&A growth well above NHC.AX's 18.38%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.